Företagskategorier: Biotech

Glycolink

4L Bioconsulting

Simsen Diagnostics

Swedish StromaBio

CuraCell Holding

Pila Pharma

Malmö-based Pila Pharma intends to participate in the development of the drug candidate XEN-D0501. The candidate has an anti-inflammatory effect, which in turn stimulates both insulin production and insulin sensitivity, both of which are crucial in diabetes.

Novocure

Novocure is a global oncology company working to extend survival in some of the most aggressive cancers by developing and commercializing its innovative TTFields therapy.

Cell4Cure

Cell4Cure AB is a Swedish, privately held cell therapy company committed to the development of treatments for the induction of immune tolerance.